Cargando…

Disparity and Diversity in NSCLC Imaging and Genomics: Evaluation of a Mature, Multicenter Database

SIMPLE SUMMARY: Lung cancer remains the leading cancer-related death across North America. As imaging is fundamental for its diagnosis, treatment, and follow-up, the presence of healthcare disparities at this level needs to be identified. Using a multicenter collated database, we aimed to identify t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kohan, Andres, Kulanthaivelu, Roshini, Hinzpeter, Ricarda, Liu, Zhihui Amy, Ortega, Claudia, Leighl, Natasha, Metser, Ur, Veit-Haibach, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093674/ https://www.ncbi.nlm.nih.gov/pubmed/37046757 http://dx.doi.org/10.3390/cancers15072096

Ejemplares similares

CT Radiomics and Whole Genome Sequencing in Patients with Pancreatic Ductal Adenocarcinoma: Predictive Radiogenomics Modeling
por: Hinzpeter, Ricarda, et al.
Publicado: (2022)

Prognostic value of PET/CT and MR-based baseline radiomics among patients with non-metastatic nasopharyngeal carcinoma
por: Kulanthaivelu, Roshini, et al.
Publicado: (2022)

Standardized classification schemes in reporting oncologic PET/CT
por: Murad, Vanessa, et al.
Publicado: (2023)

Corrigendum: Standardized classification schemes in reporting oncologic PET/CT
por: Murad, Vanessa, et al.
Publicado: (2023)

Prognostic Value of Sarcopenia and Metabolic Parameters of (18)F-FDG-PET/CT in Patients with Advanced Gastroesophageal Cancer
por: Hinzpeter, Ricarda, et al.
Publicado: (2023)

Impact of the COVID-19 Pandemic on Staging Oncologic PET/CT Imaging and Patient Outcome in a Public Healthcare Context: Overview and Follow Up of the First Two Years of the Pandemic
por: Kohan, Andres, et al.
Publicado: (2023)

Prognostic Value of [18F]-FDG PET/CT Radiomics Combined with Sarcopenia Status among Patients with Advanced Gastroesophageal Cancer
por: Hinzpeter, Ricarda, et al.
Publicado: (2022)

Combination of FDG PET/CT Radiomics and Clinical Parameters for Outcome Prediction in Patients with Hodgkin’s Lymphoma
por: Ortega, Claudia, et al.
Publicado: (2023)

(18)F-DCFPyL PET/CT in advanced high-grade epithelial ovarian cancer: A prospective pilot study
por: Metser, Ur, et al.
Publicado: (2022)

Respiratory and cardiac motion correction in positron emission tomography using elastic motion approach for simultaneous abdomen and thorax positron emission tomography-magnetic resonance imaging
por: Farag, Adam, et al.
Publicado: (2023)

(18)F-DCFPyL (PSMA) PET in the Management of Men with Biochemical Failure after Primary Therapy: Initial Clinical Experience of an Academic Cancer Center
por: Metser, Ur, et al.
Publicado: (2021)

Convolutional neural networks for improving image quality with noisy PET data
por: Schaefferkoetter, Josh, et al.
Publicado: (2020)

Promising Targets and Current Clinical Trials in Metastatic Non-Squamous NSCLC
por: Zer, Alona, et al.
Publicado: (2014)

Economic Impact of Tissue Testing and Treatments of Metastatic NSCLC in the Era of Personalized Medicine
por: Graham, Donna M., et al.
Publicado: (2014)

Nasopharyngeal Carcinoma Radiomic Evaluation with Serial PET/CT: Exploring Features Predictive of Survival in Patients with Long-Term Follow-Up
por: Dmytriw, Adam A., et al.
Publicado: (2022)

Creating Opportunities to Eliminate Disparities in Lung Cancer Outcomes: A Call for Diverse Study Populations. Comment on Kohan et al. Disparity and Diversity in NSCLC Imaging and Genomics: Evaluation of a Mature, Multicenter Database. Cancers 2023, 15, 2096
por: Washington, Caretia JeLayne, et al.
Publicado: (2023)

Combined simultaneous FDG-PET/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis
por: Cheung, Edward, et al.
Publicado: (2021)

Racial and Ethnic Trends and Disparities in NSCLC
por: Primm, Kristin M., et al.
Publicado: (2022)

Canadian Consensus Recommendations on the Management of MET-Altered NSCLC
por: Cheema, Parneet K., et al.
Publicado: (2021)

Health and Budget Impact of Liquid-Biopsy-Based Comprehensive Genomic Profile (CGP) Testing in Tissue-Limited Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients
por: Patel, Yuti P., et al.
Publicado: (2021)

Oligometastasis in Prostate Cancer: Can We Learn from Those “Excluded” from a Phase 2 Trial?
por: Glicksman, Rachel M., et al.
Publicado: (2023)

Metabolites as Prognostic Markers for Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Platinum-Doublet Chemotherapy
por: Hao, Desirée, et al.
Publicado: (2020)

Cystic lesions of the pancreatico-biliary tree: A schematic MRI approach
por: Halankar, Jaydeep, et al.
Publicado: (2017)

Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC
por: Cheema, Parneet K., et al.
Publicado: (2023)

International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology
por: Veit-Haibach, Patrick, et al.
Publicado: (2023)

Gender Differences Among Academic Radiation Oncology National Institutes of Health (NIH) Funding Recipients
por: Mutwiri, George, et al.
Publicado: (2022)

Radiomics for detecting prostate cancer bone metastases invisible in CT: a proof-of-concept study
por: Hinzpeter, Ricarda, et al.
Publicado: (2021)

XIAP inhibits mature Smac-induced apoptosis by degrading it through ubiquitination in NSCLC
por: Qin, Sida, et al.
Publicado: (2016)

The effect of prior cancer on non‐small cell lung cancer trial eligibility
por: Herman, Michael, et al.
Publicado: (2021)

Effects of Ethnicity on Outcomes of Patients With EGFR Mutation–Positive NSCLC Treated With EGFR Tyrosine Kinase Inhibitors and Surgical Resection
por: Sung, Mike R., et al.
Publicado: (2021)

Texture analysis of acute myocardial infarction with CT: First experience study
por: Hinzpeter, Ricarda, et al.
Publicado: (2017)

How disparities in gamete maturity influence the nascent conceptus, and beyond
por: Albertini, David F.
Publicado: (2020)

The clinical rehabilitation of spine and spinal cord disorders: detection and evaluation using SPECT/CT
por: Scheyerer, Max J., et al.
Publicado: (2014)

Review of the use of pretest probability for molecular testing in non-small cell lung cancer and overview of new mutations that may affect clinical practice
por: Martin, Petra, et al.
Publicado: (2017)

Next-generation ctDNA-driven clinical trials in precision immuno-oncology
por: Aggarwal, Charu, et al.
Publicado: (2023)

Osimertinib in NSCLC With Atypical EGFR-Activating Mutations: A Retrospective Multicenter Study
por: Ji, Jingran, et al.
Publicado: (2023)

SYST-06 INTRACRANIAL ACTIVITY OF TEPOTINIB IN PATIENTS WITH MET EXON 14 (METEX14) SKIPPING NSCLC ENROLLED IN VISION
por: Leighl, Natasha, et al.
Publicado: (2022)

Ethnic disparities in publicly-available pulse oximetry databases
por: Sinaki, Fatemeh Y., et al.
Publicado: (2022)

IGDB.NSCLC: integrated genomic database of non-small cell lung cancer
por: Kao, Sen, et al.
Publicado: (2012)

Establishing a Provincial Registry for Recurrent Prostate Cancer: Providing Access to PSMA PET/CT in Ontario, Canada
por: Young, Sympascho, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uq86fpbgh9vu0mc9f35de4fv9h